ApprovalTrail

Approval · Notice of Compliance 2350 · 2001

INDOCOLLYRE: Notice of Compliance 2350

Issued January 18, 2001

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2350
Date
January 18, 2001
Company
Laboratoire Chauvin S.A.34009 Montpellier, Cedex 1, Saone Et Loire, France
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Anti-inflammatory

Products in this notice

BrandDINStatus today
INDOCOLLYRE02219506Cancelled Post Market

Medicinal ingredients